Arundhati Parmar / MedCity Information:
Anagenex, which mixes AI and large-scale proprietary datasets for drug discovery, has raised a $30M Sequence A led by Catalio Capital Administration — The CEO of Anagenex believes that the corporate’s AI engine skilled on billions of information factors and iterative testing will blow different AI drug discovery startups out of the water.
[ad_2]
Source link